106 related articles for article (PubMed ID: 18391551)
1. The prognostic impact of blood group-related antigen Lewis Y and the ABH blood groups in resected non-small cell lung cancer.
Kuemmel A; Single K; Bittinger F; Faldum A; Schmidt LH; Sebastian M; Taube C; Buhl R; Wiewrodt R
Tumour Biol; 2007; 28(6):340-9. PubMed ID: 18391551
[TBL] [Abstract][Full Text] [Related]
2. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
[TBL] [Abstract][Full Text] [Related]
3. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
4. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung.
Miyake M; Taki T; Hitomi S; Hakomori S
N Engl J Med; 1992 Jul; 327(1):14-8. PubMed ID: 1317941
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Lewis y antigen in resected stage I and II non-small cell lung cancer.
Mehdi SA; Tatum AH; Newman NB; Imperato A; Daucher J; Kohman LJ; Graziano SL
Chest; 1998 Nov; 114(5):1309-15. PubMed ID: 9824007
[TBL] [Abstract][Full Text] [Related]
6. Prognostic influence of loss of blood group A antigen expression in pathologic stage I non-small-cell lung cancer.
León-Atance P; Moreno-Mata N; González-Aragoneses F; Cañizares-Carretero MÁ; Poblet-Martínez E; Genovés-Crespo M; García-Jiménez MD; Honguero-Martínez AF; Rombolá CA; Simón-Adiego CM; Peñalver-Pacual R; Alvarez-Fernández E
Arch Bronconeumol; 2012 Feb; 48(2):49-54. PubMed ID: 22153581
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
8. Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC.
Schmidt LH; Kuemmel A; Schliemann C; Schulze A; Humberg J; Mohr M; Görlich D; Hartmann W; Bröckling S; Marra A; Hillejan L; Goletz S; Karsten U; Berdel WE; Spieker T; Wiewrodt R
Lung Cancer; 2016 Feb; 92():8-14. PubMed ID: 26775589
[TBL] [Abstract][Full Text] [Related]
9. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
[TBL] [Abstract][Full Text] [Related]
11. Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance.
Laack E; Nikbakht H; Peters A; Kugler C; Jasiewicz Y; Edler L; Brümmer J; Schumacher U; Hossfeld DK
J Clin Oncol; 2002 Nov; 20(21):4279-84. PubMed ID: 12409325
[TBL] [Abstract][Full Text] [Related]
12. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
[TBL] [Abstract][Full Text] [Related]
13. A novel classification of MUC1 expression is correlated with tumor differentiation and postoperative prognosis in non-small cell lung cancer.
Nagai S; Takenaka K; Sonobe M; Ogawa E; Wada H; Tanaka F
J Thorac Oncol; 2006 Jan; 1(1):46-51. PubMed ID: 17409826
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
[TBL] [Abstract][Full Text] [Related]
15. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
[TBL] [Abstract][Full Text] [Related]
16. Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer.
Lee JS; Ro JY; Sahin AA; Hong WK; Brown BW; Mountain CF; Hittelman WN
N Engl J Med; 1991 Apr; 324(16):1084-90. PubMed ID: 1848917
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
